Larry Ramer

Larry Ramer

Larry Ramer has more than 15 years of experience in business journalism. He has worked for Globes, Israel’s most widely read business newspaper, as well as The Jerusalem Post and theflyonthewall.

Mr. Ramer’s expansive knowledge of politics enables him to provide valuable insights into how politics can affect stocks. He also focuses on contrary investing and specializes in the renewable energy and consumer discretionary sectors.

Among his highly successful, contrarian picks have been Super Micro Computer, Intel, and MGM Resorts.

You can reach him on StockTwits at @larryramer and learn more about his stock-picking record at his TipRanks profile.

Recent Articles

The State of the U.S. Economy: A Comprehensive Overview

Many are worried about the current state of the U.S. economy. Here's why some of these fears are overblown.

This Key Investor Is Dumping Tesla (TSLA) Stock

Well-known investor Cathie Wood sold over $25 million of TSLA stock yesterday as the shares rallied. TSLA stock is down about 1% today.

Global Gems: 3 High-Quality Overseas Stocks to Buy on Weakness

These three global stocks to buy cater to the upper class and have very strong future growth prospects, as well as superb financial results. 

LAAC Stock Alert: What to Know as Lithium Argentina Starts Trading

Lithium Americas Corp has split into two separate, publicly traded companies as of today. LAC stock is advancing in early trading. 

Glucose Game-Changers: 3 Diabetes Stocks to Grab on the Downturn

Diabetes stocks have retreated excessively on the belief that a new weight-loss drug will greatly reduce the number of diabetes patients.

7 Stocks Poised to Benefit From Strong Economic Growth in Q4

With the U.S. economy continuing to grow rapidly, here are seven stocks that will allow investors to benefit from that trend. 

A Real Estate Crisis Is Dragging NIO Stock Down Today

NIO stock is retreating after China's stock market fell sharply for two straight days, reaching its lowest level in a year. 

5 Reasons Higher Interest Rates WON’T Crash Stocks

The supposed unavoidable link between interest rates and the stock market has been proven by recent and more distant history. 

Cancer Drug Approval? 3 Biotech Stocks on the Brink of Breakthroughs

CAR T therapies have major advantages over traditional cancer drugs. Here are three of the best cancer drug stocks set to benefit from CAR T.

AMC Stock’s Latest Catalyst Is an Exclusive Beyonce Film

AMC stock is advancing after AMC disclosed that it would would exclusively distribute a movie based on highlights from Beyonce's tour.